200
Participants
Start Date
August 31, 2014
Primary Completion Date
October 31, 2022
Study Completion Date
October 31, 2022
Nilotinib (Tasigna ®), capsules of 150 mg
Nilotinib 2 capsules of 150 mg orally twice daily at 12 hours difference, fasting (minimum 1 hour before or 2 hours after a meal) for at least 36 months
Nilotinib (Tasigna ®) and Pegylated interferon alfa 2a (Pegasys®)
"* Nilotinib 2 capsules of 150 mg orally twice daily at 12 hours difference, fasting (minimum 1 hour before or 2 hours after a meal) for at least 36 months and~* Pegylated interferon alfa 2a subcutaneously once a week (auto-injection syringes of 135 and 90 micrograms) at 30 micrograms/week the first month alone (= priming procedure), then at 30 micrograms/2weeks the first month of combination to nilotinib and then at 45 micrograms/week thereafter until month 24 after nilotinib initiation."
Franck NICOLINI, Lyon
Collaborators (1)
Novartis
INDUSTRY
Hospices Civils de Lyon
OTHER